Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 2c, provides guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.01, $0.02 better than the analyst estimate of $1.99. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.

GUIDANCE:
The Company updates 2024 reported revenue guidance due to currency expectations and reaffirms 2024 constant currency revenue growth and adjusted1 earnings per share financial guidance.

Zimmer Biomet Holdings sees FY2024 EPS of $8.00-$8.15, versus the consensus of $8.09.

2024 Reported Revenue Change

Previosu: 4.5% - 5.5%

Updated: 4.0% - 5.0%

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• ConAgra Brands (CAG) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY27 EPS Guidance
• MongoDB (MDB) PT Lowered to $420 at BMO Capital, 'a positive for the narrative'
• Cboe and Robinhood plan binary KPI contracts for 23 companies